Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 719 | 563 | 4,445 | 767 | 1,178 |
| Receivables | 1,451 | 1,642 | 6,212 | 2,381 | 2,928 |
| Inventories | 430 | 388 | 767 | 104 | 183 |
| Other current assets | 42 | 42 | 42 | 42 | 41 |
| TOTAL | $5,214 | $5,220 | $14,563 | $5,780 | $6,531 |
| Non-Current Assets | |||||
| PPE Net | 8,370 | 8,492 | 8,022 | 997 | 1,182 |
| Investments And Advances | 5,461 | 5,747 | 7,069 | 7,131 | 7,185 |
| Intangibles | 4,775 | 4,804 | 4,834 | 335 | 404 |
| Other Non-Current Assets | 1,006 | 998 | 610 | 1,852 | 2,186 |
| TOTAL | $19,612 | $20,040 | $20,535 | $10,314 | $10,957 |
| Total Assets | $24,827 | $25,260 | $35,099 | $16,094 | $17,488 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 423 | 432 | 765 | 819 | 900 |
| Accounts payable and accrued liabilities | 623 | 648 | 1,309 | 1,174 | 1,584 |
| Accrued Expenses | 1,176 | 917 | 1,316 | 390 | 273 |
| Other current liabilities | 586 | 563 | 1,092 | 117 | 121 |
| TOTAL | $4,745 | $4,496 | $12,953 | $5,985 | $6,363 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,001 | 4,350 | 7,365 | 3,822 | 3,877 |
| TOTAL | $4,702 | $4,948 | $8,066 | $3,813 | $3,875 |
| Total Liabilities | $9,441 | $9,444 | $21,019 | $9,798 | $10,238 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,006 | 6,006 | 5,246 | 2,096 | 2,096 |
| Common Shares | 6 | 6 | 5 | 2 | 2 |
| Retained earnings | -37,973 | -37,445 | -33,253 | -31,351 | -30,562 |
| Other shareholders' equity | -1,469 | -1,567 | -1,560 | -2,032 | -1,868 |
| TOTAL | $15,386 | $15,816 | $14,080 | $6,296 | $7,249 |
| Total Liabilities And Equity | $24,827 | $25,260 | $35,099 | $16,094 | $17,488 |